Baxter International Inc. vs. InspireMD, Inc.
Baxter International Inc. (BAX) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BAX | NSPR | |
|---|---|---|
| Market Cap | $11.79 billion | $36.53 million |
| Revenue (TTM) | $11.47 billion | $10.84 million |
| Net Income (TTM) | $-1,063,000,000 | $-52,482,000 |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | NSPR | |
|---|---|---|
| Price / Book | 1.91 | 1.16 |
| Price / Sales | 1.03 | 3.37 |
BAX and NSPR split the valuation factors evenly.
Profitability
| BAX | NSPR | |
|---|---|---|
| Net Margin | -9.27% | -484.11% |
| Return on Equity | -17.20% | -166.55% |
BAX leads on 2 of 2 profitability factors.
Dividend
| BAX | NSPR | |
|---|---|---|
| Dividend Yield | 0.18% | — |
BAX and NSPR split the dividend factors evenly.
Risk & Sentiment
| BAX | NSPR | |
|---|---|---|
| Short Interest | 1.03% | 3.14% |
BAX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, NSPR overview, NSPR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.